SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Three Amigos Stock Thread

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: brogan who wrote (18937)2/21/2000 8:48:00 PM
From: Ken W  Read Replies (1) of 29382
 
brogan:

This is from the Jan, 6 release:

Under the terms of the agreement, SGF will acquire treasury shares of DRAXIS Pharma at a premium as compared to DRAXIS Health's equity cost base. Following completion of the transaction, the shareholders of DRAXIS Pharma will be: DRAXIS Health (65.7%), SGF (31.8%) and DRAXIS Pharma senior management (2.5%). Closing of the transaction is expected to take place on or about January 31, 2000 and is subject to, among other things, satisfactory completion of due diligence and the negotiation and signing of definitive agreements.

If SGF aquires shares of DRAX at a premium to the treasury cost basis DRAX gets the difference in profit? If that is fact then the bottom line of the company will improve over last quarter. I wonder how much of a premium we are talking about. I like that SGF is "investing" and not taking convertibles or perferred shares..a big plus in my book. This should be very interesting tomorrow.

The bride and I are going to Vegas for a couple of days to the Award Recognition Assoc. Convention, so tomorrow I'll be home all day to watch and yeha all over the place....I hope.

Ken
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext